← back to search

Masato Murakami

Novartis (Switzerland) · CH
Area of research
Condensed Matter Physics · Cardiology and Cardiovascular Medicine
Research interest
Research focused on stat and Clinical trial, with related work in Insertional mutagenesis, Essential thrombocythemia, Pathogenesis. Notable publications include 'JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response', 'The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice', and 'Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf −/− mouse model'.
h-index
citations
687
works
4
NIH funding
primary concept
email

Recent publications

A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression
PLoS ONE 2019cited by 11position: middledoi
Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf <sup>−/−</sup> mouse model
Proceedings of the National Academy of Sciences 2017cited by 62position: middledoi
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Cancer Cell 2016cited by 303position: middledoi
JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
Cancer Discovery 2015cited by 311position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Vincent Romanet · Novartis (Switzerland)3 papers (2015–2019)Emilie A. Chapeau · Novartis (Switzerland)2 papers (2017–2019)Ralph Tiedt · Yale Cancer Center2 papers (2017–2019)Francesco Hofmann · Novartis (Switzerland)2 papers (2017–2019)Emeline Mandon · Novartis (Switzerland)2 papers (2017–2019)Thomas Radimerski · Novartis (Switzerland)2 papers (2015–2019)Esther Sutter · Novartis (Switzerland)1 papers (2017–2017)Roland Rad · Molecular Oncology (United States)1 papers (2017–2017) · 1 papers (2015–2015)Minsuk Kwak · Yale Cancer Center1 papers (2015–2015)Antoine de Weck · Centre for Human Genetics1 papers (2017–2017)Joseph Lehár · Fondation pour la Recherche Stratégique1 papers (2017–2017)Franziska Michor · Harvard University1 papers (2015–2015)Michael Rugaard Jensen · Novartis (Switzerland)1 papers (2017–2017)Maria Kleppe · Memorial Sloan Kettering Cancer Center1 papers (2015–2015)Moriko Ito · Novartis (Switzerland)1 papers (2019–2019)Matthias Mueller · University Hospital Heidelberg1 papers (2019–2019)Audrey Kauffmann · Novartis (Switzerland)1 papers (2017–2017) · 1 papers (2015–2015)Rong Fan · Yale University1 papers (2015–2015)